Renal cancer immunotherapy: a ray of hope or regression to the mean?
Stadler
W
W
D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D011379:Prognosis; D016896:Treatment Outcome
D016898:Interferon-alpha; D007376:Interleukin-2